Opendata, web and dolomites

DermoSafe 2.0

An Integral Platform for the Early Diagnosis of Skin Cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DermoSafe 2.0 project word cloud

Explore the words cloud of the DermoSafe 2.0 project. It provides you a very rough idea of what is the project "DermoSafe 2.0" about.

patient    avoiding    tracking    offsets    fast    combat    posed    facilitates    practitioners    history    pharmacies    demonstrated    artificial    detection    performing    dermosafe    capability    professional    quality    overpass    buy    intelligence    service    days    2024    experts    cognitive    investment    automatic    roi    reduce    limitations    evolution       136    check    flow    appointment    budget    unquestionable    dermobrain    exploded    requirement    pattern    broad    cash    incidence    employing    healthcare    population    time    context    cumulative    provides    dermatologists    cancer    platform    hence    integral    diminished    tool    screening    classification    anxiety    lesion    ict    deploying    42    thermometer    skin    reg    computing    rating    identification    opportunity    lack    workforce    dermoscopy    imaging    speeds    ing    once    community    seems    business    reducing    medical    accurate    specialised    image    dermatology    recognition    considering   

Project "DermoSafe 2.0" data sheet

The following table provides information about the project.

Coordinator
DermoSafe SA 

Organization address
address: PARC SCIENTIFIQUE DE L'EPFL (PSE) BATIMENT D
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.dermosafe.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DermoSafe SA CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

DermoSafe® is an integral platform based on DermoBrain, a cognitive computing system which will enable the early detection of skin cancer for broad population. The ICT-based approach facilitates and speeds the professional analysis of potential skin lesion by employing Dermoscopy Imaging. DermoSafe provides an accurate tool that allows patient performing the needed increased analysis to combat the exploded incidence of skin cancer without the requirement of an appointment with general practitioners or dermatologists, reducing lead time of the skin analysis results from 42 to 3 days. Hence, patient uncertainty and anxiety is clearly diminished. Furthermore, DermoSafe enables a fast and easy access to Dermoscopy experts to the healthcare professional community (pharmacies, general practitioners and dermatologists). DermoSafe has demonstrated capability to overpass the limitations posed by current Dermoscopy devices for early and broad screening by avoiding the need of a high investment to buy the equipment as well as offsets the lack of specialised dermatology workforce. Once implemented in the healthcare system and at pharmacies, DermoSafe can reduce the skin cancer budget up to 136,000€/patient. Since our platform and associated service will make the use of Dermoscopy imaging as broad as the use of a thermometer, the business opportunity seems unquestionable. The objective of this project is the further development of DermoBrain, to enable (1) skin lesion pattern recognition and identification for automatic history tracking and evolution rating, (2) automatic image quality check, and (3) image automatic classification considering also the patient medical context by artificial intelligence. By deploying DermoSafe platform in Europe, we aim to achieve a cumulative cash flow of 10.7 M€ by 2024, resulting in a ROI of 4.2

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DERMOSAFE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DERMOSAFE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More  

DetectInMen (2019)

Infection detection in human semen

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More